HNRNPL and atherosclerosis: Although its role has to be defined in SMC phenotype determination and atherosclerosis development, the hnRNPL decrease may concur, according to the several processes it modulates in different cell types, to the cytostatic effect of furoxan treatment on in vitro SMCs.